Clene Investor Relations Material
Latest events
Q2 2025
14 Aug, 2025
Investor Presentation
14 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Clene Inc
Access all reports
Clene Inc. is a biopharmaceutical company focused on developing nanotechnology-based therapies for neurodegenerative diseases. The company specializes in therapeutic candidates targeting conditions such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson’s disease. Its lead programs utilize proprietary nanocrystal technology to enhance cellular energy production and neuroprotection. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.
Key slides for Clene Inc
Investor Presentation
Clene Inc
Investor Presentation
Clene Inc
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
CLNN
Country
🇺🇸 United States